#Pfizer is moving forward with its Phase 2/3 trial in the pediatric population and expects to provide #Vaccines for #COVID19 to children between 5-11 in the fall, and soon after for those 4 and younger, if studies show immune response and safety. https://www.theepochtimes.com/pfizer-advances-its-covid-19-vaccine-trial-for-children-11-and-younger_3851504.html?utm_source=minds